Study Overview: This study looks at how safe and effective a drug called ozanimod is for people with moderate to severe ulcerative colitis (UC). Ulcerative colitis is a disease that causes swelling and sores in the colon. The study also checks how the drug affects the quality of life of the participants and their body’s response through certain tests called biomarkers.

Eligibility: To join, you must have had UC symptoms for at least 3 months and have a score between 4 and 9 on a test called the modified Mayo score, which measures UC severity. You also need a recent colonoscopy report. You cannot join if you have severe issues like a toxic megacolon or if you’ve had certain surgeries.

Key Points to Consider:

• The study is open-label, meaning both you and your doctor will know what treatment you're receiving.
• It focuses on moderate to severe UC cases, so suitable candidates must meet specific health criteria.
• The study aims to improve life quality and assess safety, but there may be risks, so discuss with your doctor.